US Aesthetic Medicine Market To Exceed Valuation Of US$ 71.49 Billion By 2033 | Astute Analytica

(MENAFN- GlobeNewsWire - Nasdaq) With an emphasis on self-care and wellness, the aesthetic medicinemarket flourishes, driven by technological advancements and a rising appetite for non-invasive procedures, enabling individuals to enhance their appearance while prioritizing convenience and safety.

New Delhi, Dec. 16, 2024 (GLOBE NEWSWIRE) -- According to the latest study from Astute Analytica, the US aesthetic medicine market is projected to hit the market valuation of US$ 71.49 billion by 2033 from US$ 25.17 billion in 2024 at a CAGR of 12.65% during the forecast period 2025–2033.

The aesthetic medicine market in the United States is poised for significant growth and transformation in the coming years, driven by technological advancements, increasing societal acceptance, and a broadening demographic embracing cosmetic enhancements. One of the key factors propelling this growth is the continued innovation in non-invasive treatment options. With over 15 million minimally invasive procedures performed annually, patients are increasingly opting for treatments that offer effective results with minimal downtime. The introduction of novel technologies, such as advanced laser systems and next-generation injectable products, is expected to further stimulate market growth. For instance, the launch of new hyaluronic acid fillers with extended longevity is anticipated to enhance patient satisfaction and repeat utilization.

Request Sample Copy @

Demographic shifts are also influencing the market's trajectory. The male segment is expanding, with men accounting for over 1.3 million cosmetic procedures, signaling a shift in societal perceptions of aesthetic treatments. Additionally, the aging population, particularly the Baby Boomer generation, remains a significant market segment, seeking procedures that offer rejuvenation without extensive recovery periods. The number of cosmetic procedures among individuals aged 55 and older has surpassed 4 million annually, emphasizing this group's impact on the industry. Digitalization and social media continue to shape consumer awareness and expectations. Platforms like Instagram and TikTok have become influential in disseminating information about aesthetic procedures, contributing to an informed and engaged consumer base. Virtual consultations have also become more prevalent, with an estimated 70% of practitioners offering telemedicine options, enhancing accessibility for patients.

Regulatory developments may influence the pace of innovation and market entry of new treatments in the aesthetic medicine market. However, the commitment to patient safety ensures that advancements in aesthetic medicine meet rigorous standards. As the industry navigates these regulatory landscapes, collaboration between practitioners, manufacturers, and regulatory bodies will be essential.

Key Findings in the US Aesthetic Medicine Market

Market Forecast (2033)	US$ 71.49 Billion
CAGR	12.65%
By Procedure Type	Non-Invasive (62.57%)
By Gender	Female (85.33%)
By Age Group	30-45 Years (40.41%)
By End Users	Medical Spas & Beauty Clinics (47.57%)
Top Drivers	Growing demand for minimally invasive cosmetic procedures among all age groups. Technological advancements enhancing safety and effectiveness of aesthetic treatments. Increasing societal acceptance and desire for youthful appearances and self-enhancement.
Top Trends	Rising popularity of non-surgical treatments like injectables and laser therapies. Influence of social media shaping aesthetic preferences and consumer decisions. Expansion of the male demographic seeking aesthetic medical procedures.
Top Challenges	Regulatory hurdles and stringent FDA approval processes for new procedures. High costs limiting access to treatments for a broader population segment. Ethical concerns over unrealistic beauty standards impacting mental health.

Transformative Landscape of Aesthetic Medicine Market: Non-Invasive Trends, Consumer Dynamics, and Market Leaders

In 2023, non-invasive aesthetic procedures have surged to the forefront of the U.S. aesthetic medicine market, reflecting a significant consumer shift toward treatments that offer effective results with minimal downtime. Americans invested over $6 billion in non-invasive procedures this year, signaling robust demand for options like Botulinum Toxin injections, laser skin resurfacing, and dermal fillers. The popularity of these treatments is evident, with more than 10 million Botox sessions administered nationwide, each costing an average of $400. Advances in technology have also made laser hair removal a top choice, with the average session priced at $285 and contributing substantially to market growth. The preference for subtle enhancements without surgical risks has positioned non-invasive procedures as the leading segment in aesthetic medicine.

The age group of 30 to 45 years has emerged as the largest consumer segment in the aesthetic medicine market as of 2023, undergoing approximately 5 million procedures. Individuals within this demographic are experiencing the initial signs of aging and are motivated to maintain a youthful appearance for both personal satisfaction and professional advantage. With an average disposable income of $60,000, they have the financial means to invest in aesthetic treatments, spending an average of $1,500 per person annually. Their active engagement is further influenced by a high exposure to social media trends and a strong inclination toward wellness and self-care practices. This combination of economic capacity and cultural influence drives their dominance in the market.

Women continue to overwhelmingly dominate the aesthetic medicine landscape, accounting for over 12 million procedures performed in 2023. The cosmetic industry has recognized and reinforced this trend by allocating more than $10 billion toward advertising campaigns targeting female consumers, emphasizing beauty maintenance and anti-aging solutions. Social media's impact is profound, with 8 out of 10 women citing platforms like Instagram and TikTok as significant influences on their decision to pursue aesthetic treatments. The rise of beauty influencers and the constant portrayal of idealized images have heightened body consciousness among women, prompting a surge in demand for cosmetic enhancements to align with socially propagated beauty standards.

Medical spas and beauty clinics have ascended as the primary end-users in the U.S. aesthetic medicine market in 2023, with over 5,000 establishments generating a combined revenue exceeding $5 billion. These venues offer a unique blend of medical expertise and spa-like relaxation, attracting clients seeking effective treatments in a comfortable setting. The average client expenditure at medical spas has reached $2,500 annually, reflecting consumer willingness to invest in comprehensive aesthetic and wellness experiences. The accessibility of these clinics, often located in urban centers, along with their adoption of advanced technologies like AI-driven skincare assessments, has solidified their dominance. Their ability to provide personalized care and a wide array of services meets the contemporary consumer's demand for convenience and holistic well-being in aesthetic treatments.

Request for a Discount on this Report Before Purchase:

Top 5 Players Control over 43% revenue Share of the US Aesthetic Medicine Market

AbbVie Inc. (Allergan Aesthetics), Johnson & Johnson (Mentor), Cynosure Lutronic Inc., Galderma, Revance Therapeuticsare top 5 Players in the market. Wherein, AbbVie Inc., through its Allergan Aesthetics division, leads the U.S. aesthetic medicine market with an 18.5% share, driven by its extensive product portfolio, strong brand reputation, and commitment to innovation. Central to AbbVie's dominance is Botox, a widely recognized brand for treating wrinkles and fine lines. With a proven track record and high consumer trust, Botox remains a pillar of the company's success even in a competitive market. Complementing Botox is the JUVÉDERM® line of dermal fillers, which addresses a variety of facial aesthetic needs. The company also offers the CoolSculpting® body contouring system, broadening its appeal to consumers seeking non-invasive body shaping solutions. This comprehensive range of products allows AbbVie to meet diverse consumer preferences in both facial and body aesthetics, further solidifying its market leadership.

AbbVie's dominance has been bolstered by key developments, particularly its $63 billion acquisition of Allergan in 2020. This acquisition expanded AbbVie's product offerings, strengthened its market reach, and enhanced its research and development capabilities. AbbVie is actively innovating with projects like BoNT/E, a next-generation botulinum neurotoxin designed for faster results, which aligns with evolving consumer preferences for quick and effective treatments. The company also prioritizes inclusivity in its offerings, as seen in initiatives like the DREAM program, which aims to improve equity in aesthetic treatments by addressing diverse skin types and ethnic backgrounds. These initiatives, alongside its innovative pipeline of over 60 programs globally, reflect AbbVie's commitment to advancing the aesthetic medicine field.

Looking forward, AbbVie is well-positioned to sustain its leadership in the growing aesthetic medicine market. By focusing on personalized treatments and training providers to meet individual aesthetic goals, the company enhances patient satisfaction and outcomes. Strategic partnerships, such as the agreement with Cypris Medical, and continued investments in research and development further reinforce its market position. As the North American aesthetic medicine market is projected to grow significantly, AbbVie's strategic approach ensures it remains at the forefront of the industry.

Recent Developments Shaping the US Aesthetic Medicine Market

2023

• Restylane Eyelight received approval for the treatment of undereye hollows, marking a significant advancement in facial aesthetics.
• Alastin's C-Radical Defense was launched, introducing innovative elastin-preserving qualities to the skincare market.
• Skinvive by Allergan was introduced in the US market, aimed at improving skin smoothness.
• Aesthetic Partners, a clinical aesthetics-focused practice management company, announced a strategic partnership with Norwest, a global investment firm. This partnership aims to accelerate growth in new markets and expand across existing and new clinics.
• Millburn Laser Center entered into a partnership with Schweiger Dermatology Group, part of a series of add-on acquisitions in the outpatient care and medical aesthetics sector.
• Scherl Dermatology also partnered with Schweiger Dermatology Group, further consolidating the outpatient care and medical aesthetics sector

2024

• April 2024: Hahn & Company acquired Cynosure and announced plans to integrate it with Lutronic. This merger is set to unite two leading global providers of energy-based medical aesthetic treatment systems under the parent company Cynosure Lutronic, Inc.
• September 27, 2024: The FDA approved Motiva USA, LLC's SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants for marketing. This approval was based on a study involving 560 patients and includes requirements for post-approval studies to assess long-term clinical performance.

US Aesthetic Medicine Market Key Players:

• AbbVie Inc. (Allergan Aesthetics)
• Johnson & Johnson (Mentor)
• Cynosure Lutronic Inc.
• Galderma
• Revance Therapeutics
• Candela Medical
• Bausch Health Companies Inc
• Lumenis, Inc.
• Evolus Inc.
• Cutera Inc.
• Other Prominent Players

Key Segmentation:

By Procedure Type

• Invasive Surgical Procedures
  • Breast Augmentation
  • Breast Reduction
  • Breast Lift
  • Liposuction
  • Arm Lift
  • Body Contouring
  • Thigh Lift
  • Cheek Augmentation
  • Chin Surgery
  • Rhinoplasty
  • Facelift Surgery
  • Others
• Non- Invasive Surgical Procedures
  • Botulinum Toxin
  • Nonsurgical Rhinoplasty
  • Dermal Fillers
  • Laser Skin Resurfacing
  • Laser Hair Removal
  • Skin Rejuvenation and Resurfacing
  • Chemical Peel
  • Others

By Age Group

• 18-29 Years
• 30-45 Years
• 46-60 Years
• Above 60 Years

By Gender

• Male
• Female
• Transgender

By End User

• Hospitals
• Dermatology Clinics
• Medical Spas and Beauty Clinics

Inquire more about this report before purchase:

About Astute Analytica

Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.

Contact Us:
Astute Analytica
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
For Sales Enquiries: ...
Website:
LinkedIn | Twitter | YouTube

CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: ... Website:

MENAFN16122024004107003653ID1108997375